Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma (original) (raw)

Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma

The Oncologist, 2012

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

David Linch

Bone Marrow Transplantation, 2008

View PDFchevron_right

Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol

Daniel Rubio

Biology of Blood and Marrow Transplantation, 2006

View PDFchevron_right

Editors: A. Spyridonidis and I. Sakellari 6. Stem-cell transplantation for Hodgkin's Lymphoma

A. Symeonidis

View PDFchevron_right

Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study

Filippo Russo

American Journal of Hematology, 2007

View PDFchevron_right

Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT

S. Genadieva-Stavric

Bone Marrow Transplantation, 2020

View PDFchevron_right

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin lymphoma

Norman Franke

Haematologica-the Hematology Journal, 2010

View PDFchevron_right

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

Jan Walewski

BMC Cancer

View PDFchevron_right

Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment

Gregorio Jaimovich

Bone Marrow Transplantation

View PDFchevron_right

Analysis of relapsed/refractory Hodgkin lymphoma treated with autologous transplantation: A single-center experience

Girish Badarkhe

Indian Journal of Medical and Paediatric Oncology, 2020

View PDFchevron_right

Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience

Haleema Saeed

Journal of Global Oncology, 2019

View PDFchevron_right

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party o...

Joan Besalduch

Haematologica, 2012

View PDFchevron_right

Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma

Eldad Dann

Bone Marrow Transplantation, 1997

View PDFchevron_right

Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma

Todd Defor

Biology of Blood and Marrow Transplantation, 2006

View PDFchevron_right

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

Job Kievit

2013

View PDFchevron_right

High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis

Lamia Torjemane

PubMed, 2007

View PDFchevron_right

Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile

alejandra rodriguez

Revista Brasileira de Hematologia e Hemoterapia, 2015

View PDFchevron_right

Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA / SFGM-TC study group

Franck Morschhauser

Haematologica, 2015

View PDFchevron_right

Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis

Stephen Schuster

American Journal of Hematology, 2017

View PDFchevron_right

Richard Maziarz

Biology of Blood and Marrow Transplantation, 2009

View PDFchevron_right

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

Hugo Castro-Malaspina

British Journal of Haematology, 2009

View PDFchevron_right

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma

Norman Franke

Haematologica, 2010

View PDFchevron_right

Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: a SWOG and Blood & Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)

Grzegorz Woźniak

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017

View PDFchevron_right

Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant

Hillard M Lazarus

Current treatment options in oncology, 2005

View PDFchevron_right

A Review of Autologous Stem Cell Transplantation in Lymphoma

Faisal Akbar

Current hematologic malignancy reports, 2017

View PDFchevron_right

Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma (original) (raw)

Related papers